
OrSense
Innovative non-invasive hemoglobin measurement solutions for blood banks and medical facilities.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | Series H | ||
Total Funding | 000k |
Related Content
OrSense is a medical technology company specializing in non-invasive hemoglobin measurement solutions. The company serves blood banks, hospitals, and other medical facilities, providing advanced devices that measure hemoglobin levels without the need for blood samples. Operating in the healthcare market, OrSense's business model revolves around the sale and distribution of its proprietary medical devices. Revenue is generated through direct sales, partnerships, and long-term service agreements with healthcare providers. The company's technology is particularly valuable in settings such as blood donation centers, intensive care units (ICUs), and operating rooms, where quick and accurate hemoglobin measurement is critical. OrSense's innovative approach not only enhances patient care but also improves operational efficiency for medical staff.
Keywords: Non-invasive, Hemoglobin, Blood banks, Medical devices, Healthcare, ICU, Blood donation, Patient care, Hematology, Medical technology.